Comparison of maternal and fetal outcomes of intermittent and daily iron supplementation among pregnant women in NAUTH Nnewi, Nigeria: A randomized control study

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

PACTR

Registry ID

PACTR202310594848644

Enrollment

Registered

2023-10-03

Start date

2023-10-02

Completion date

Unknown

Last updated

2026-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pregnancy and Childbirth

Interventions

Daily iron group

Intermittent iron group

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: All consenting singleton pregnancies presenting to antenatal clinic after 12 weeks of gestation.

Exclusion criteria

Exclusion criteria: • Pregnancies below 12 weeks • Multiple gestation. • Pregnancies complicated by haemoglobinopathies, • Established iron deficiencies anaemia • Chronic maternal illness eg Tuberculosis, malignancies. • Maternal smoking.

Design outcomes

Primary

Measure	Time frame
• Mean haemoglobin level in both groups • The change in haemoglobin level after 4 weeks of iron therapy in both groups	—

Secondary

Measure	Time frame
• Mean Ferritin level • Side effect profile (nausea, vomiting, constipation, diarrhea, heartburn) • Preterm labour • Preterm premature rupture of fetal membranes (PROM) • Maternal adherence level. • Mode of delivery • Neonatal birth weight • APGAR score	—

Countries

Nigeria

Contacts

Public ContactGeorge Eleje

Consultant Obstetrician and Gynaecologist Dept of OBGYN NAUTH

georgel21@yahoo.com+2348068117444

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Sep 19, 2026